Dual Targeting of Histone Methyltransferase G9a and DNA‐Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Dual Targeting of Histone Methyltransferase G9a and DNA‐Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma

Published:2019-01-04 Issue:2 Volume:69 Page:587-603
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Bárcena‐Varela Marina¹,Caruso Stefano²,Llerena Susana³⁴,Álvarez‐Sola Gloria¹⁴,Uriarte Iker¹⁴,Latasa M. Ujue¹,Urtasun Raquel¹,Rebouissou Sandra²,Alvarez Laura¹,Jimenez Maddalen¹,Santamaría Eva⁴⁵,Rodriguez‐Ortigosa Carlos¹⁴⁵,Mazza Giuseppe⁶,Rombouts Krista⁶,San José‐Eneriz Edurne⁷⁵,Rabal Obdulia⁸,Agirre Xabier⁷⁵,Iraburu Maria⁹,Santos‐Laso Alvaro⁹¹⁰,Banales Jesus M.⁴⁹¹⁰,Zucman‐Rossi Jessica²^ORCID,Prósper Felipe⁷⁵,Oyarzabal Julen⁸,Berasain Carmen¹⁴⁵,Ávila Matías A.¹⁴⁵,Fernández‐Barrena Maite G.¹⁴⁵

Affiliation:

1. Hepatology Program Cima‐University of Navarra Pamplona Spain

2. Functional Genomics of Solid Tumors, Inserm U1162 Université Paris Descartes, Université Paris Diderot Université Paris 13, IUH France

3. Marqués de Valdecilla University Hospital Santander Spain

4. CIBERehd Instituto de Salud Carlos III Madrid Spain

5. Instituto de Investigaciones Sanitarias de Navarra‐IdiSNA Pamplona Spain

6. Institute for Liver and Digestive Health University College London London United Kingdom

7. Oncohematology Program Cima‐University of Navarra Pamplona Spain

8. Molecular Therapeutics Program Cima‐University of Navarra Pamplona Spain

9. Department of Biochemistry and Genetics University of Navarra Pamplona Spain

10. Biodonostia Research Institute Donostia University Hospital Ikerbasque, San Sebastian Spain

Funder